Literature DB >> 15712784

Memory impairment in patients with cirrhosis.

Funda Bahceci1, Bulent Yildirim, Melih Karincaoglu, Ibrahim Dogan, Birsen Sipahi.   

Abstract

BACKGROUND AND AIM: Subclinical hepatic encephalopathy (HE) in cirrhotic patients is usually characterized by memory impairment and psychomotor slowing. Our aim was to investigate memory status in cirrhotic patients with and without clinically overt HE.
MATERIAL AND METHODS: Thirty-two cirrhotic patients (10 female and 22 male) aged 49 +/- 17 years and 20 healthy subjects (six female and 14 male) aged 46 +/- 12 years were included in the study. Memory status was defined by Wechsler Memory Scale, verbal memory process and complex memory process tests.
RESULTS: Grade-1 HE was detected in 7 (22%) patients with cirrhosis. We detected 36 to 92% decrement in various memory tests in cirrhotic patients without HE as compared to healthy subjects. The scores for all psychometric testing results were significantly lower in cirrhotic patients without HE as compared to healthy subjects. We detected 42.9 to 100% decrement in various memory tests in cirrhotic patients with HE than cirrhotic patients without HE. However, there was no statistical significant difference between cirrhotic patients with and without HE. There was no statistical significant difference in cirrhotic patients with Child-Pugh A, B, and C.
CONCLUSION: In conclusion, memory status was influenced in which patients with cirrhosis yet has a normal mental and neurological status to routine clinical examination (subclinical HE). Occasionally, decreased memory performance may adversely affect the satisfaction and lifestyle of these patients. Therefore, subclinical HE is an important social problem.

Entities:  

Mesh:

Year:  2005        PMID: 15712784      PMCID: PMC2568771     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  25 in total

1.  Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.

Authors:  A Das; R K Dhiman; V A Saraswat; M Verma; S R Naik
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

2.  Subclinical portal-systemic encephalopathy.

Authors:  N Gitlin
Journal:  Am J Gastroenterol       Date:  1988-01       Impact factor: 10.864

3.  Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study.

Authors:  J W Moore; A A Dunk; J R Crawford; H Deans; J A Besson; G De Lacey; T S Sinclair; N A Mowat; P W Brunt
Journal:  J Hepatol       Date:  1989-11       Impact factor: 25.083

4.  The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.

Authors:  N Gitlin; D C Lewis; L Hinkley
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

5.  Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach.

Authors:  G K Sood; S K Sarin; J Mahaptra; S L Broor
Journal:  Am J Gastroenterol       Date:  1989-02       Impact factor: 10.864

6.  Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

Authors:  H Schomerus; W Hamster; H Blunck; U Reinhard; K Mayer; W Dölle
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

7.  Visual attention in cirrhotic patients: a study on covert visual attention orienting.

Authors:  P Amodio; P Marchetti; F Del Piccolo; G Campo; C Rizzo; R M Iemmolo; G Gerunda; L Caregaro; C Merkel; A Gatta
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

8.  Memory impairments concomitant with nonalcoholic cirrhosis.

Authors:  R E Tarter; A M Arria; J Carra; D H Van Thiel
Journal:  Int J Neurosci       Date:  1987-02       Impact factor: 2.292

9.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  Objective measurement of hepatic encephalopathy by means of automated EEG analysis.

Authors:  C C Van der Rijt; S W Schalm; G H De Groot; M De Vlieger
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1984-05
View more
  3 in total

1.  Cognitive assessment of patients with minimal hepatic encephalopathy in Brazil.

Authors:  D S Torres; J Abrantes; C E Brandão-Mello
Journal:  Metab Brain Dis       Date:  2013-04-28       Impact factor: 3.584

2.  Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease.

Authors:  Veronika Rackayová; Emmanuelle Flatt; Olivier Braissant; Jocelyn Grosse; Daniela Capobianco; Paola Mastromarino; Matthew McMillin; Sharon DeMorrow; Valérie A McLin; Cristina Cudalbu
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

3.  Mapping metabolic brain activity in three models of hepatic encephalopathy.

Authors:  Natalia Arias; Marta Méndez; Camino Fidalgo; María Ángeles Aller; Jaime Arias; Jorge L Arias
Journal:  Int J Hypertens       Date:  2013-03-14       Impact factor: 2.420

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.